Sweden· SE-20130208000015
Brinzolamide Sandoz 10 mg/ml Ögondroppar, suspension
A brinzolamide product containing brinzolamide, registered in Sweden by Sandoz A/S. The same ATC class is registered in 18 of our 19 countries.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
Where it is registered
Brinzolamide is registered in 18 of 19 countries.
Countries holding a registration under ATC S01EC04 (brinzolamide), each read from that country’s own register.
- This record: Sweden, from Swedish Medical Products Agency (Sweden)
- 10 of them publish a price we can compare per daily dose
Brinzolamide · ATC S01EC04
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Brinzolamide
- Manufacturer
- Sandoz A/S
- Country
- Sweden (SE)
- ATC code
- S01EC04
- ATC class
- Brinzolamide
- Defined daily dose
- 0.2 ml, AT
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20130208000015
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
43 interactions on record for brinzolamide.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Brinzolamide · interactions on record
43 records
- 4 severe
- 39 info
Most severe, free to view
- Acetylsalicylic acidB01AC06severe
- Salicylic acidD01AE12severe
- Acetylsalicylic acidN02BA01severe
- Salicylic acidS01BC08severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Brinzolamide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAZOPTNovartis Europharm Limited, Dublin
- NetherlandsAZOPT 10 mg/ml oogdruppels, suspensieNovartis Europharm Limited
- FranceAZOPT 10 mg/ml, collyre en suspensionNOVARTIS EUROPHARM (IRLANDE)
- United StatesAzoptSandoz Inc
- FinlandAZOPTNovartis Europharm Limited
- NorwayAzopt2care4 ApS
- IrelandAzopt 10 mg/ml eye drops, suspensionNovartis Europharm Limited
- BelgiumAzopt 10 mg/mlPI Pharma
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Aicisi, Brinzo-Vision
- Bulgaria · Бритил
- Czechia · Brinzolamid Olikla, Brinzolamide Stada
- Germany · Aicisi, Brinzo-Vision
- Denmark · Brinzolamid Stada, Brinzolamide Hexal
- Estonia · Brinzolamide Elvim, Brinzolamide Hexal
- Spain · Aicisi, Brinzolamida Stada
- Finland · Brinzolamide Accord, Brinzolamide Hexal
- France · Aicisi, Brinzolamide Arrow
- United Kingdom (Northern Ireland) · Brinzolamide Accord-Uk, Brinzolamide Blumont Pharma
- Greece · Aicisi, Optonium
- Ireland · Brinzolamide Accord Healthcare Ireland, Brinzolamide Rowex
- Iceland · Azopt
- Italy · Aicisi, Brinzaflux
- Liechtenstein · Azopt
- Lithuania · Brinzolamide Elvim
- Latvia · Brinzolamide Elvim, Brinzolamide Hexal
- Netherlands · Brinzo-Vision, Brinzolamide Pharmathen
- Norway · Azopt, Brinzolamide Hexal
- Poland · Optilamid
- Portugal · Aicisi, Brinzolamida Accord
- Slovakia · Brinzolamid Olikla, Brizadopt
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e4cd68ed-b345-4fbc-a56e-e1be113c232c GET /v1/drugs/e4cd68ed-b345-4fbc-a56e-e1be113c232c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL"
],
"se_npl_id": "20130208000015",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20130208000015",
"product_doc_link": "https://docetp.mpa.se/LMF/Brinzolamide%20Sandoz%20eye%20drops%2C%20suspension%20SmPC_09001bee807a2025.pdf"
}See everything about brinzolamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.